| Lubna B Munshi, MD | |
|
8040 Princeton Glendale Rd, West Chester, OH 45069-5802 | |
| (513) 246-1900 | |
| Not Available |
| Full Name | Lubna B Munshi |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 18 Years |
| Location | 8040 Princeton Glendale Rd, West Chester, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1750723433 | NPI | - | NPPES |
| 0301569 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 35.133847 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bethesda North | Cincinnati, OH | Hospital |
| Mccullough-hyde Memorial Hospital | Oxford, OH | Hospital |
| Good Samaritan Hospital | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Trihealth H Llc | 1850570458 | 668 |
News Archive
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Clinical descriptors can assist clinicians in identifying patients with various stages of atherothrombosis (abnormal fatty deposits in an artery) who are at high-risk of future cardiovascular events, according to a study that will appear in the September 22 issue of JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology meeting in Stockholm.
Even 30 minutes of exercise per week has the potential to significantly reduce a woman's risk of developing cervical cancer, according to a study from scientists at Roswell Park Cancer Institute (RPCI). The case-control study was recently published in the Journal of Lower Genital Tract Disease.
The Dispensary of Hope is pleased to announce that sanofi-aventis U.S., the U.S. affiliate of sanofi-aventis, a leading global pharmaceutical company, has become the latest pharmaceutical company to participate in the Dispensary's Continued Access Program, which provides uninsured patients with access to medicines that they otherwise couldn't afford.
An expert panel convened today at the annual meeting of the Radiological Society of North America (RSNA) to discuss medical imaging appropriateness, ionizing radiation from imaging procedures and efforts under way to curb overutilization, decrease radiation dose and educate patients on the risks and benefits of medical imaging.
› Verified 6 days ago
| Entity Name | Osu Internal Medicine Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740231448 PECOS PAC ID: 5496651408 Enrollment ID: O20031210000658 |
News Archive
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Clinical descriptors can assist clinicians in identifying patients with various stages of atherothrombosis (abnormal fatty deposits in an artery) who are at high-risk of future cardiovascular events, according to a study that will appear in the September 22 issue of JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology meeting in Stockholm.
Even 30 minutes of exercise per week has the potential to significantly reduce a woman's risk of developing cervical cancer, according to a study from scientists at Roswell Park Cancer Institute (RPCI). The case-control study was recently published in the Journal of Lower Genital Tract Disease.
The Dispensary of Hope is pleased to announce that sanofi-aventis U.S., the U.S. affiliate of sanofi-aventis, a leading global pharmaceutical company, has become the latest pharmaceutical company to participate in the Dispensary's Continued Access Program, which provides uninsured patients with access to medicines that they otherwise couldn't afford.
An expert panel convened today at the annual meeting of the Radiological Society of North America (RSNA) to discuss medical imaging appropriateness, ionizing radiation from imaging procedures and efforts under way to curb overutilization, decrease radiation dose and educate patients on the risks and benefits of medical imaging.
› Verified 6 days ago
| Entity Name | Trihealth H Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811215742 PECOS PAC ID: 1850570458 Enrollment ID: O20110128000356 |
News Archive
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Clinical descriptors can assist clinicians in identifying patients with various stages of atherothrombosis (abnormal fatty deposits in an artery) who are at high-risk of future cardiovascular events, according to a study that will appear in the September 22 issue of JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology meeting in Stockholm.
Even 30 minutes of exercise per week has the potential to significantly reduce a woman's risk of developing cervical cancer, according to a study from scientists at Roswell Park Cancer Institute (RPCI). The case-control study was recently published in the Journal of Lower Genital Tract Disease.
The Dispensary of Hope is pleased to announce that sanofi-aventis U.S., the U.S. affiliate of sanofi-aventis, a leading global pharmaceutical company, has become the latest pharmaceutical company to participate in the Dispensary's Continued Access Program, which provides uninsured patients with access to medicines that they otherwise couldn't afford.
An expert panel convened today at the annual meeting of the Radiological Society of North America (RSNA) to discuss medical imaging appropriateness, ionizing radiation from imaging procedures and efforts under way to curb overutilization, decrease radiation dose and educate patients on the risks and benefits of medical imaging.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lubna B Munshi, MD 8040 Princeton Glendale Rd, West Chester, OH 45069-5802 Ph: (513) 246-1900 | Lubna B Munshi, MD 8040 Princeton Glendale Rd, West Chester, OH 45069-5802 Ph: (513) 246-1900 |
News Archive
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Clinical descriptors can assist clinicians in identifying patients with various stages of atherothrombosis (abnormal fatty deposits in an artery) who are at high-risk of future cardiovascular events, according to a study that will appear in the September 22 issue of JAMA. The study is being released early online to coincide with its presentation at the European Society of Cardiology meeting in Stockholm.
Even 30 minutes of exercise per week has the potential to significantly reduce a woman's risk of developing cervical cancer, according to a study from scientists at Roswell Park Cancer Institute (RPCI). The case-control study was recently published in the Journal of Lower Genital Tract Disease.
The Dispensary of Hope is pleased to announce that sanofi-aventis U.S., the U.S. affiliate of sanofi-aventis, a leading global pharmaceutical company, has become the latest pharmaceutical company to participate in the Dispensary's Continued Access Program, which provides uninsured patients with access to medicines that they otherwise couldn't afford.
An expert panel convened today at the annual meeting of the Radiological Society of North America (RSNA) to discuss medical imaging appropriateness, ionizing radiation from imaging procedures and efforts under way to curb overutilization, decrease radiation dose and educate patients on the risks and benefits of medical imaging.
› Verified 6 days ago
Dr. Abdul R. Wattar, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 7700 University Ct, West Chester, OH 45069 Phone: 513-867-3331 Fax: 513-867-2667 | |
Katherine A Lyons, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 8040 Princeton Glendale Rd, West Chester, OH 45069 Phone: 513-862-4957 Fax: 513-862-4952 | |
Dr. Chengxi Wang, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 7675 Wellness Way, West Chester, OH 45069 Phone: 134-758-2485 Fax: 513-475-5815 | |
Dr. Lekshmi Suseelan Misra, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 7700 University Dr, West Chester, OH 45069 Phone: 513-298-7325 Fax: 513-298-7406 | |
Dr. Lakkaraj Rajasekhar, MD Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 7218 Stone Harbour Ln Ste 200, West Chester, OH 45069 Phone: 513-266-2458 Fax: 513-947-0500 | |
Charles R Hattemer, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 7690 Discovery Dr, West Chester, OH 45069 Phone: 513-475-8521 Fax: 513-475-7480 | |
Olugbenga Olanrele Olowokure, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 7675 Wellness Way, West Chester, OH 45069 Phone: 513-475-8500 Fax: 513-584-4281 |